“One or more cell lines with an origin that can be traced back to human fetal tissue has been used in laboratory tests associated with the vaccine program.”
QUICK FACTS:
- Melissa Strickler, Pfizer Insider and Manufacturing Quality Auditor, leaked internal emails to Project Veritas that show corporate executives telling staff to be secretive about the company’s use of human fetal tissue in laboratory testing of the Covid-19 vaccine.
- “From the perspective of corporate affairs, we want to avoid having the information on the fetal cells floating out there,” wrote Vanessa Gelman, Pfizer’s Senior Director of Worldwide Research, in one email.
- “We have been trying as much as possible not to mention the fetal cell lines,” Gelman wrote in another email.
- Gelman goes on to admit that Pfizer has “tried really hard not to share” the fact that “[o]ne or more cell lines with an origin that can be traced back to human fetal tissue has been used in laboratory tests associated with the vaccine program.”
- In another leaked email, Pfizer Chief Scientific Officer Philip Dormitzer reveals the company utilizes what are called “HEK293T” cells “for the IVE assay” in making Pfizer’s mRNA vaccine and that these HEK293T cells “are ultimately derived from an aborted fetus.” “HEK” stands for “human embryonic kidney” cells which come from a human fetus who was aborted in 1973 and have been grown and copied since then to be used in pharmaceutical experimentation. “293” stands for the 293rd experiment performed by Dr. Frank Graham to develop these HEK cells.
- “We have not received any questions from policymakers or media [regarding fetal cells being used in the production of Pfizer’s COVID vaccine] in the last few weeks, so we want to avoid raising this, if possible,” wrote Gelman. “The risk of communicating this right now outweighs any potential benefit we could see, particularly with general members of the public who may take this information and use it in ways we may not want out there.”
WATCH THE PROJECT VERITAS INTERVIEW WITH PFIZER WHISTLEBLOWER MELISSA STRICKLER:
Jon Fleetwood is Managing Editor for American Faith.
